Emergent BioSolutions
EBS
#8541
Rank
NZ$0.48 B
Marketcap
NZ$9.40
Share price
-6.36%
Change (1 day)
-46.67%
Change (1 year)

Market capitalization of Emergent BioSolutions (EBS)

Market cap: NZ$0.48 Billion

As of November 2026 Emergent BioSolutions has a market cap of NZ$0.48 Billion. This makes Emergent BioSolutions the world's 8541th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Emergent BioSolutions from 2006 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$0.48 B-57.81%
2025NZ$1.14 B44.11%
2024NZ$0.79 B303.52%
2023NZ$0.19 B-78.78%
2022NZ$0.92 B-72.9%
2021NZ$3.42 B-47.98%
2020NZ$6.58 B58.91%
2019NZ$4.14 B-8.47%
2018NZ$4.52 B38.6%
2017NZ$3.26 B70.04%
2016NZ$1.91 B-16.65%
2015NZ$2.30 B75.78%
2014NZ$1.31 B27.91%
2013NZ$1.02 B46.5%
2012NZ$0.69 B-9.84%
2011NZ$0.77 B-27.14%
2010NZ$1.06 B84.56%
2009NZ$0.57 B-57.15%
2008NZ$1.34 B585.02%
2007NZ$0.19 B-55.04%
2006NZ$0.43 B

End of Day market cap according to different sources

On Nov 19th, 2026 the market cap of Emergent BioSolutions was reported to be:

NZ$0.48 Billion
by Nasdaq info icon info icon
NZ$0.48 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
NZ$286.36 B 59,182.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$597.29 B 123,549.49%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$174.86 B 36,100.15%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
NZ$10.23 M-97.88%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
NZ$0.34 B-28.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ$4.00 B 729.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$82.03 B 16,883.20%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel